Transforming Treatment in Multiple Myeloma: The Evolving Role of CAR-T Therapy
home / meeting-of-the-minds / transforming-treatment-in-multiple-myeloma-the-evolving-role-of-car-t-therapy
Meeting of the Minds video series features an actor portrayal of a hypothetical patient profile developed for educational purposes by leading oncology experts, based on characteristics of patients with various cancer types as seen in clinical practice.
EP. 2: Assessing Patient Eligibility for CAR-T Therapy
December 23rd 2024This segment explores factors influencing patient candidacy for CAR-T therapy, including age, fitness, and relapse specifics, and evaluates key findings from the KarMMa trials to compare ide-cel with other second-line treatment options for multiple myeloma.
